Luciole is a start-up biotechnology company discovering and developing small molecule activators of OGG1, to accelerate the repair of oxidative damage to mitochondrial DNA.
Luciole Pharmaceuticals is developing first-in-class agents as disease-modifying therapeutics for diseases of aging. Our efforts have the potential to lead to the discovery of a novel, safe, and very effective oral medicine for obesity and metabolic syndrome, fatty liver disease and neurodegeneration, which will improve patients’ quality-of-life and increase their life expectancy.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 5 Commonwealth Rd.,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- luciolepharma.com
- HQ
- Natick, MA
- Competitors
- Haisco-USA Pharmaceuticals, Inc., Luckwel Pharmaceuticals Inc., Creative Options, Inc., Protide Pharmaceuticals, Inc., Alphageneron Pharmaceuticals, Alexion Pharmaceuticals, Inc., NeuroPhage Pharmaceuticals, Inc., Fusion Pharmaceuticals, Breakwater Biotech, Inc., Lumena Pharmaceuticals, Inc..
Luciole Pharmaceuticals, Inc. Questions
Luciole Pharmaceuticals, Inc.'s website is luciolepharma.com
Luciole Pharmaceuticals, Inc.'s LinkedIn profile is https://www.linkedin.com/company/luciole-pharmaceuticals-inc
Luciole Pharmaceuticals, Inc. has
3 employees.
View email and phone details for 3
employees at Luciole Pharmaceuticals, Inc..
Luciole Pharmaceuticals, Inc.'s industry is
Biotechnology Research
Luciole Pharmaceuticals, Inc.'s top competitors are
Haisco-Usa Pharmaceuticals, Inc.,
Luckwel Pharmaceuticals Inc.,
Creative Options, Inc.,
Protide Pharmaceuticals, Inc.,
Alphageneron Pharmaceuticals,
Alexion Pharmaceuticals, Inc.,
Neurophage Pharmaceuticals, Inc.,
Fusion Pharmaceuticals,
Breakwater Biotech, Inc.,
Lumena Pharmaceuticals, Inc..
Luciole Pharmaceuticals, Inc.'s categories are Biotechnology Research
Luciole Pharmaceuticals, Inc.'s founding year is 2020
